Concepedia

Author

Rachel Jones

University of CambridgeORCID

Also Known As

Kim Mynard, R B Jones, R JONES, R Jones, R. B. Jones, R. Jones, R.B. Jones, R.T. Jones, Rachel B Jones, Rachel B. Jones

141

Publications

7.8K

Citations

37

H-Index

51

Concepts

All Affiliations

University of CambridgeAddenbrooke's HospitalUniversity of BirminghamCharles UniversityUniversity College London
RJ

About

Rachel Jones is an author at University of Cambridge specializing in medicine, immunology, and autoimmune disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

887

2

Health Sciences

1

1

75

3

Allergy

1

1

75

4

Diabetes

1

1

82

5

Gastroenterology

1

1

66

Rachel Jones

×

43

Publications

7K

Citations

33

H-Index

YearCitations

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

Rachel Jones, Jan Willem Cohen Tervaert, Thomas Häuser,

New England Journal of Medicine

2010

1.7K

Modification and validation of the Birmingham Vasculitis Activity Score (version 3)

Chetan Mukhtyar, R Lee, Denise Scott Brown,

Annals of the Rheumatic Diseases

2008

1.2K

Long‐term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re‐treatment

Kenneth G. C. Smith, Rachel Jones, Stella Burns,

Arthritis & Rheumatism

2006

399

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody–associated vasculitis

Rachel Jones, Alastair Ferraro, Afzal Chaudhry,

Arthritis & Rheumatism

2009

355

Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease

Darren M. Roberts, Rachel Jones, Rona Smith,

Journal of Autoimmunity

2014

290

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial

Rachel Jones, Shunsuke Furuta, Jan Willem Cohen Tervaert,

Annals of the Rheumatic Diseases

2015

263

Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody–associated vasculitis

Rona Smith, Rachel Jones, Mary‐Jane Guerry,

Arthritis & Rheumatism

2012

250

Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial

Rachel Jones, Thomas F. Hiemstra, José Ballarín,

Annals of the Rheumatic Diseases

2019

221

Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

Rona Smith, Rachel Jones, Ulrich Specks,

Annals of the Rheumatic Diseases

2020

168

The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease

Helena Marco, Rona Smith, Rachel Jones,

BMC Musculoskeletal Disorders

2014

145

Page 1